Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | 3C2H3O2.Al |
| Molecular Weight | 204.1136 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
[Al+3].CC([O-])=O.CC([O-])=O.CC([O-])=O
InChI
InChIKey=WCOATMADISNSBV-UHFFFAOYSA-K
InChI=1S/3C2H4O2.Al/c3*1-2(3)4;/h3*1H3,(H,3,4);/q;;;+3/p-3
DescriptionCurator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Curator's Comment: Description was created based on several sources, including
https://www.google.com/patents/US2824042 | https://www.ncbi.nlm.nih.gov/pubmed/22718290 | https://www.ncbi.nlm.nih.gov/pubmed/15516810 | https://www.ncbi.nlm.nih.gov/pubmed/10211213 | https://www.drugs.com/monograph/aluminum-acetate.html
Burow invented an astringent antiseptic solution of aluminium acetate in water to relieve the itching and inflammation of minor skin irritations. At present the oflicial U. S. P. procedure to made Burow's solution involves the reaction of aluminum sulfate, calcium carbonate and acetic acid to form aluminum sub-acetate, also termed basic aluminum acetate.
The solution is available as an over-the-counter drug for topical administration, with brand names including Domeboro. Burow's solution has been shown to be effective against chronic suppurative otitis media and otitis externa. It is active against bacteria resulting in damage to the cell wall.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL2364031 |
|||
Target ID: GO:0042310 |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | DOMEBORO Approved UseTemporarily relieves minor skin irritations due to:
– Poison ivy | – Poison oak
– Poison sumac | – Insect bites
– Athlete’s foot | – Rashes caused by soaps, detergents, cosmetics, or jewelry |
|||
| Curative | DOMEBORO Approved UseThis medication is used to treat an outer ear infection (external otitis). This product contains acetic acid/aluminum acetate, a combination that stops the growth of bacteria and fungus. Treating the infection reduces pain and swelling in the ear. Wetness in the ear canal can help bacteria and fungus to grow. This medication also causes drying of the ear canal, helping to cure the infection. |
PubMed
| Title | Date | PubMed |
|---|---|---|
| The ineffectiveness of aluminum subacetate in rheumatoid arthritis. | 1948 Apr 8 |
|
| Aluminum fluoride inhibition of glucocorticoid receptor inactivation and transformation. | 1990 Apr 10 |
|
| The antibacterial activity of acetic acid and Burow's solution as topical otological preparations. | 1998 Oct |
|
| Effects of trace metal compounds on HIV-1 reverse transcriptase: an in vitro study. | 1999 May |
|
| Intravascular hemolysis in aluminium phosphide poisoning. | 1999 Sep |
|
| Fluoride plus aluminum: useful tools in laboratory investigations, but messengers of false information. | 2002 |
|
| Bone cell mitogenic action of fluoroaluminate and aluminum fluoride but not that of sodium fluoride involves upregulation of the insulin-like growth factor system. | 2002 May |
|
| [Pharmaceutical and pharmacological evaluation of Burow's solution (aluminum acetate solution), hospital preparation, and development of its rapid preparation method]. | 2004 Nov |
|
| Aluminum: new recognition of an old problem. | 2005 Dec |
|
| Effects of aluminum on the nervous system and its possible link with neurodegenerative diseases. | 2005 Nov |
|
| Some aspects of astroglial functions and aluminum implications for neurodegeneration. | 2006 Aug 30 |
|
| Aluminum and other metals in Alzheimer's disease: a review of potential therapy with chelating agents. | 2006 Nov |
|
| Ototoxic effect of Burow solution applied to the guinea pig middle ear. | 2007 Aug |
|
| Neurological adverse events of immunization: experience with an aluminum adjuvanted meningococcal B outer membrane vesicle vaccine. | 2007 Oct |
|
| Relationship between physical and chemical properties of aluminum-containing adjuvants and immunopotentiation. | 2007 Oct |
|
| Reversible myocardial injury associated with aluminum phosphide poisoning. | 2007 Sep |
|
| Ablative laser resurfacing: high-energy pulsed carbon dioxide and erbium:yttrium-aluminum-garnet. | 2007 Sep-Oct |
|
| Retrospective analysis of 4-week inhalation studies in rats with focus on fate and pulmonary toxicity of two nanosized aluminum oxyhydroxides (boehmite) and pigment-grade iron oxide (magnetite): the key metric of dose is particle mass and not particle surface area. | 2009 May 17 |
|
| New insight into artifactual phenomena during in vitro toxicity assessment of engineered nanoparticles: study of TNF-α adsorption on alumina oxide nanoparticle. | 2013 Apr |
|
| Gene expression profile of mouse fibroblasts exposed to a biodegradable iron alloy for stents. | 2013 Nov |
|
| 1H NMR spectroscopic analysis detects metabolic disturbances in rat urine on acute exposure to heavy metal tungsten alloy based metals salt. | 2014 Mar 25 |
|
| Molecular basis of carcinogenicity of tungsten alloy particles. | 2015 Mar 15 |
Sample Use Guides
DOMEBORO® SOOTHING SOAK
– dissolve 1 to 3 packets in a pint (16 oz) of cool or warm water
– stir until fully dissolved; do not strain or filter. The resulting mixture contains 0.16% (1 packet), 0.32% (2 packets), or 0.48% (3 packets) aluminum acetate and is ready for use
For use as a soak:
– soak affected area for 15 to 30 minutes as needed, or as directed by a doctor
– repeat 3 times a day or as directed by a doctor
– discard solution after each use.
For use as a compress or wet dressing:
– soak a clean, soft cloth in the solution.
– apply cloth loosely to affected area for 15 to 30 minutes
– repeat as needed or as directed by a doctor
– discard solution after each use
Route of Administration:
Topical
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
CFR |
21 CFR 176.170
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
||
|
CFR |
21 CFR 347.12
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
||
|
NCI_THESAURUS |
C28394
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB12809MIG
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
CHEMBL1201015
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
m1590
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | Merck Index | ||
|
DTXSID30890496
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
C47387
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
4998
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
139-12-8
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
C013396
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
80EHD8I43D
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
DB14518
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
100000077667
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
Aluminium triacetate
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
80EHD8I43D
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
205-354-1
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | |||
|
17609
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY | RxNorm | ||
|
8757
Created by
admin on Fri Dec 15 15:23:17 GMT 2023 , Edited by admin on Fri Dec 15 15:23:17 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SUBSTANCE RECORD
